Online Program Home
My Program

Abstract Details

Activity Number: 254
Type: Contributed
Date/Time: Monday, August 1, 2016 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract #319568
Title: Dose-Ranging Design and Analysis Based on MCP-Mod to Identify the Minimum Effective Dose (MED)
Author(s): Ying Zhang* and Su Chen and Yihan Li and Wangang Xie and Yijie Zhou and Li Wang and Alan Hartford
Companies: AbbVie and AbbVie and AbbVie and AbbVie and AbbVie and AbbVie and AbbVie
Keywords: Dose response ; Minimum effective dose ; MCP-Mod
Abstract:

In Phase 2b studies, it is of interest to investigate possible dose-response relationships to identify the minimum effective dose (MED) to be used in confirmatory studies. In traditional dose response studies, pairwise comparisons between placebo and each investigational dose is used to claim trial success and to make dose recommendations. Recently, a new dose ranging study design and analysis method was proposed based on a novel model-based approach--Multiple Comparison Procedures & Modeling (MCP-Mod), which detects multiple general dose response trends accounting for model uncertainty. With the same design power, MCP-Mod generally requires a smaller sample size per arm than the study design based on pairwise comparison, thus allowing for more study arms (more dose levels) given a fixed total sample size. Via simulation, we compare the performance of identifying the MED and other operating characteristics using design/analysis approaches based on pairwise comparison versus MCP-Mod under similar total study size. Furthermore, advantages and disadvantages of the different approaches will be discussed.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2016 program

 
 
Copyright © American Statistical Association